SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-045653
Filing Date
2022-08-12
Accepted
2022-08-12 17:12:11
Documents
1
Period of Report
2022-08-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4009
  Complete submission text file 0001209191-22-045653.txt   5713
Mailing Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807
Business Address 520 U.S. HIGHWAY 22, SUITE 204 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Issuer) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O KYTHERA BIOPHARMACEUTICALS, INC. 30930 RUSSELL RANCH ROAD, 3RD FLOOR WESTLAKE VILLAGE CA 91362
Business Address
Sandoval Elisabeth (Reporting) CIK: 0001632295 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38356 | Film No.: 221161185